Study shows benefit of finding second tumor early
Early detection of a woman’s second breast cancer can cut her risk of premature death in half, researchers said on Wednesday.
While it makes sense that detecting a second tumor early improves the chances of survival, until now there has been little evidence that it does, the researchers said, adding that this had implications for monitoring of patients.
The findings published in the Annals of Oncology underline the importance of follow-up treatment and close monitoring for women who have survived a first tumor, Nehmat Houssami of the University of Sydney in Australia and colleagues reported.
"Intuitively, it makes sense to consider that early detection of second breast cancers will improve prognosis, since breast cancer survivors have a long-term risk of developing further disease or relapse in either breast,” she said in a statement.
“However, due to a paucity of evidence about this until now, current recommendations on surveillance of breast cancer survivors vary substantially between countries and organizations.”
Breast cancer is the leading cancer killer of women worldwide, according to the American Cancer Society. The group estimates about 465,000 women died from breast cancer globally in 2007, with 1.3 million new cases diagnosed.
Early detection through mammography screening and improved treatments has driven declines in breast cancer deaths in developed countries, it says.
The researchers looked at 1,044 women who attended a clinic in Italy between 1980 and 2005 after developing a second breast tumor.
They found that after adjusting for the fact some tumors grow more slowly than others, a woman’s chances of survival were improved by between 27 percent and 47 percent compared to women whose cancers were detected at a later stage when symptoms started to appear.
“Recommendations on follow-up after treatment of early breast cancer should consider our findings, which suggest that early detection of second breast cancer events improves prognosis,” Houssami’s team wrote.
LONDON (Reuters)
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
| Interactive Quiz: |

